Quadratus Lumborum Block for Total Abdominal Hysterectomy

Launched by CLINICAL CENTER NIŠ · Mar 1, 2023

Keywords

ClinConnect Summary

Participants will be randomly allocated into two groups. Experimental group will have QLB type 2 at the end of surgery, before emergence from general anesthesia. Control group will not have QLB.

All cases will be done under general anesthesia. During the surgery, the patients will be monitored with 5-lead electrocardiography, pulse oximetry, non-invasive blood pressure and end-expiratory CO2.

Standardized general anesthesia include induction with a propofol bolus of 1.5-2.5mg/kg and rocuronium 0.6mg/kg. Fentanyl 2 mcg/kg will be given at induction, and repeated to keep the blood pressure ...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. endometrial carcinoma or uterine fibroids
• • 2. American society of anesthesiologists (ASA) physical status 1-3,
• • 3. Participant's body weight \> 50 kg,
• • 4. Written informed consent signed.
• Exclusion Criteria:
• • 1. Patient's refusal
• • 2. Allergies to any study medication
• • 3. Local skin infection on the site of QLB injection
• • 3. Body mass index \> 40 kg/m2 4. Inability to comprehend or participate in scoring scales 4. Deformations that could possibly affect the spread of the local anesthetic in the quadratus lumborum muscle plane 5. Quadratus lumborum muscle plane not seen in ultrasound examination 6. Patients on regular use of opioids 7. Psychiatric disorders